Preoperative BMI and weight play a key role in bariatric surgery outcomes

New research being presented at this year's Euroanaesthesia Congress in Milan, Italy (4-6 June), suggests that preoperative body mass index (BMI) and weight play an important role in outcomes following bariatric (obesity) surgery.

The study by Dr Michael Margarson and colleagues from St Richard's Hospital, Chichester, UK, confirms the long-suspected view that peri-operative deaths and admission to ICU are significantly more likely in patients with the highest weight and BMI.

Surgical procedures are some of the most successful ways to help people with severe obesity to lose weight, but unfortunately some patients will experience complications. Although the absolute risk of dying after bariatric surgery is very low, less than one in 500 overall, our findings from one hospital in the UK highlight a strong link between patients in the highest 10% of preoperative BMI (more than 62 kg/m2) and weight (more than 182kg/28 stone) and confirms a markedly increased risk of ICU admission and death within 30 days of surgery."

Dr Michael Margarson, St Richard's Hospital

As the worldwide obesity rate continues to climb, so do the number of people seeking weight-loss surgery. Bariatric surgery-;which involves procedures that either limit the amount of food that can be consumed or reduce food absorption-;can result in lasting weight loss and lower risks of chronic conditions associated with severe obesity including cardiovascular disease, high blood pressure, type 2 diabetes and cancer. However, it has previously not been clear how preoperative BMI and weight influence the risk of complications and death after surgery.

To find out more, researchers analysed data from 4,170 adults (average age 44 years, 78% female) who underwent weight loss surgery (ie, sleeve gastrectomy, gastric bypass, biliopancreatic diversion, or gastric banding) at St Richard's Hospital in Chichester between 2006 and 2020.

BMI measurements were available for all patients, however accurate weight measurements were only available for 85% (3,545 patients). Participants were divided into ten equal-sized groups (deciles) based on their BMI and weight prior to surgery, and researchers analyzed differences in post-operative admission to ICU and death within 30 days.

Eight bariatric surgery patients died within a month of surgery, four after leaving the hospital. Nevertheless, patients in the highest BMI decile (˃62 kg/m2) were more than 5 times more likely to die within 30 days of the procedure than those in the other 90%-;although deaths were rare in absolute terms.

Statistical analysis shows those participants in the highest BMI decile (above 62 kg/m2)were 12 times more likely to be admitted to ICU than those in the lowest decile (below 39 kg/m2), while ICU admission rates were nearly 16 times higher among those in the highest weight category (above 182kg) compared with the lowest weight category (below 105kg) (0.8% vs 13.3%).

"We suspect there may be a selection bias towards elective admission of larger patients, so teasing apart essential admissions from semi-elective admissions will be the next step of this analysis," explains Dr Margarson.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
PDX engraftment predicts high recurrence and poor survival in triple-negative breast cancer